Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

azanidazole

Known as: 4-(2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl)-2-pyrimidinamine (E) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Drugs containing the imidazole ring have been reported to exert a potent inhibi­tory effect on microsomal mixed function mono… Expand
1987
1987
The mutagenicity of metronidazole and azanidazole has been extensively reported. Previous experiments demonstrated, by means of… Expand
1985
1985
The genotoxicity of nitroimidazoles and, in particular, their potential carcinogenicity has been demonstrated. In order to… Expand
1983
1983
Twenty-five 5-nitroimidazole and two 5-nitrothiazole derivatives were tested for mutagenicity as well as for antibacterial… Expand
1980
1979
1979
Azanidazole can be measured in plasma and urine by reversed-phase high-performance liquid chromatography employing UV detection… Expand
1978
1978
A toxicological study of 4-[(E)-2-(1-methyl-5-nitro-1H-imidazol-2-yl)-ethenyl]-2-pyrimidinamine (azanidazole, Triclose), a new… Expand
1977
1977
More than 135 new 2-methyl-5-nitroimidazoles substituted in 1-position and 1-methyl-5-nitroimidazoles substituted in 2-position… Expand